Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist

May 6, 2025

Dr. Skupsky details how dermatologists can use ancillary testing to guide their decision making on atypical pigmented lesions.

MORE EXPERT PERSPECTIVES IN MELANOMA

Abel Jarell, MD, FAAD: Identifying the Risk of Central Nervous System Metastasis Using the 31-Gene Expression Profile Test

Dr. Jarell discusses a recently presented poster,¹ on which he served as an investigator, which reported results of a retrospective analysis conducted in a cohort...

PLAY

Jason Rizzo, MD, PhD: Evaluating Melanoma-specific Survival Stratification and Survival Benefit of Gene Testing in Patients with Melanoma

Dr. Rizzo discusses research that he and his co-authors presented at the 2025 AAD Annual Meeting, which validated the performance of the 31-gene expression profile...

PLAY

JCAD

Journal of Clinical and Aesthetic Dermatology

JCAD Archives

Hadas Skupsky, MD, FAAD: Pigmented Lesion Management for the Dermatologist

MORE EXPERT PERSPECTIVES IN MELANOMA